Emergent BioSolutions (EBS) FCF Margin (2011 - 2026)
Emergent BioSolutions' (EBS) quarterly FCF Margin came in at 23.19% in Q1 2026, down 1653.0% year-on-year from 1.49% in Q1 2025, and down 144.27% quarter-over-quarter from 52.39% in Q4 2025.
Emergent BioSolutions (EBS) FCF Margin (2011 - 2026) Analysis & Trends
Emergent BioSolutions' FCF Margin history runs 16 years deep, the most recent figure standing at 23.19% for Q1 2026.
- On a quarterly basis, FCF Margin fell 1653.0% year-over-year to 23.19% in Q1 2026; TTM through Mar 2026 was 21.81%, a 1038.0% increase from a year earlier, with the FY2025 full-year figure at 22.75%, up 1932.0% from the prior year.
- FCF Margin retreated to 23.19% in Q1 2026 per EBS's latest filing, from 52.39% in the prior quarter.
- Across five years, FCF Margin topped out at 73.46% in Q2 2025 and bottomed at 116.74% in Q1 2023.
- The 5-year median for FCF Margin is 6.66% (2025), against an average of 0.51%.
- Across the five-year window, FCF Margin sank 9394 bps in 2023 and jumped 11052 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 53.18% in 2022, then sank by 107 bps to 3.72% in 2023, then plunged by 1025 bps to 41.91% in 2024, then surged by 225 bps to 52.39% in 2025, then sank by 144 bps to 23.19% in 2026.
- Per Business Quant, the three latest EBS FCF Margin figures stand at 23.19% (Q1 2026), 52.39% (Q4 2025), and 1.04% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Emergent BioSolutions | 389.77 Mn | 228.27 Mn | 84.10 Mn | -23.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.19% |
| Dec 31, 2025 | 52.39% |
| Sep 30, 2025 | 1.04% |
| Jun 30, 2025 | 73.46% |
| Mar 31, 2025 | -6.66% |
| Dec 31, 2024 | -41.91% |
| Sep 30, 2024 | 50.34% |
| Jun 30, 2024 | 70.80% |
| Mar 31, 2024 | -21.94% |
| Dec 31, 2023 | -3.72% |
| Sep 30, 2023 | 28.98% |
| Jun 30, 2023 | -39.72% |
| Mar 31, 2023 | -116.74% |
| Dec 31, 2022 | 53.18% |
| Sep 30, 2022 | -42.48% |
| Jun 30, 2022 | -19.66% |
| Mar 31, 2022 | -22.80% |
| Dec 31, 2021 | 42.04% |
| Sep 30, 2021 | 16.91% |
| Jun 30, 2021 | -7.66% |